Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mediplant is a Swiss research institute and service provider specializing in the domestication, selection, and cultivation of medicinal and aromatic plants. Based in Conthey, the organization bridges the gap between academic research and industrial production for the pharmaceutical, cosmetic, and food industries. Their expertise includes the development of high-yield plant varieties, optimized cultivation techniques, and efficient extraction processes for bioactive compounds. Notably, Mediplant has played a significant role in the global supply of artemisinin for anti-malarial treatments through its work on Artemisia annua. The company provides contract research and manufacturing services, supporting the development of plant-based active ingredients from laboratory scale to industrial production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mediplant.